Step into the future of medical education with our exclusive webinar series from February 25-26, designed specifically for Pharma leaders. This transformative series will showcase the 2025 Pharma ...
Pfizer’s Braftovi (encorafenib) regimen has been granted accelerated approval by the US Food and Drug Administration (FDA) to ...
As the world’s third largest pharmaceutical market, Japan accounted for approximately 6% of the $1.5tn in global ...
AstraZeneca’s Tagrisso (osimertinib) has been approved by the European Commission (EC) to treat a new subset of lung cancer ...
If you are struggling to navigate the complexity of early commercialisation, rest assured, you are not alone. Clinical trial ...
Is your medical education strategy reaching the right HCPs in the formats they prefer? Discover actionable insights to ...
For many years the pharma sector has been vocal in its commitment to a ‘patient-focused’ approach. As a result, there does seem to be more attention on the patient across med affairs, marketing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback